IGC Pharma (IGC) Payables (2011 - 2026)
IGC Pharma (IGC) posted quarterly Payables of $1.3 million for Q1 2026, up 45.19% year-over-year from $883000.0 in Q1 2025, and up 26.43% quarter-over-quarter from $1.0 million in Q4 2025.
IGC Pharma (IGC) Payables (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Payables for 16 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables rose 45.19% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 45.19% YoY), while the FY2026 annual figure was $1.3 million, up 45.19% from the prior year.
- Payables rose to $1.3 million in Q1 2026 per IGC's latest filing, from $1.0 million in the prior quarter.
- Across five years, Payables topped out at $1.6 million in Q3 2023 and bottomed at $459000.0 in Q2 2022.
- Historically, Payables has averaged $905588.2 across 5 years, with a median of $835000.0 in 2024.
- Annual changes were most pronounced in 2022 — Payables tumbled 70.29% — and 2023, when it surged 217.86%.
- IGC Pharma's Payables stood at $466000.0 in 2022, then jumped by 39.06% to $648000.0 in 2023, then gained by 28.86% to $835000.0 in 2024, then climbed by 21.44% to $1.0 million in 2025, then advanced by 26.43% to $1.3 million in 2026.
- Business Quant data shows IGC's Payables at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $628000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 628,000.00 |
| Jun 30, 2025 | 933,000.00 |
| Mar 31, 2025 | 883,000.00 |
| Dec 31, 2024 | 835,000.00 |
| Sep 30, 2024 | 768,000.00 |
| Jun 30, 2024 | 771,000.00 |
| Mar 31, 2024 | 773,000.00 |
| Dec 31, 2023 | 648,000.00 |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 530,000.00 |
| Dec 31, 2022 | 466,000.00 |
| Sep 30, 2022 | 926,000.00 |
| Jun 30, 2022 | 459,000.00 |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 360,000.00 |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.55 Mn |